lactose has been researched along with rofecoxib in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Alberti, S; Di Francesco, L; Dovizio, M; John, CM; Maier, TJ; Marcantoni, E; Münch, G; Patrignani, P; Sgambato, A; Steinhilber, D; Suess, B | 1 |
2 other study(ies) available for lactose and rofecoxib
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Pharmacological inhibition of platelet-tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cells.
Topics: Binding Sites; Blood Platelets; Cell Communication; Cell Line, Tumor; Colonic Neoplasms; Cyclin B1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Down-Regulation; Epithelial-Mesenchymal Transition; Galectin 3; Gene Expression; Glycoproteins; HT29 Cells; Humans; Immunoglobulin Fc Fragments; Lactones; Lactose; Platelet-Derived Growth Factor; Receptors, Collagen; RNA, Messenger; Sulfones; Up-Regulation | 2013 |